series-a
Stage
1
Investors
About
Nanovery develops nucleic acid nanorobotics (NANs) technology to provide comprehensive solutions for RNA therapeutic analysis and biomarker quantification, simplifying testing protocols and elevating research precision in biotechnology.
Explore Nanovery's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.